Catheter‐related blood stream infection · patients with a central venous catheter
Longer intervals (5‐15 days) (intervention) showed no clear difference in catheter‐related blood stream infection (CRBSI) compared with shorter intervals (2‐5 days) (control) between dressing changes (low certainty).
1 finding from 1 review
RR 1.42 [0.4, 4.98]
Studies not reported
Low
All‐cause mortality · patients with a central venous catheter
Longer intervals (5‐15 days) (intervention) showed no clear difference in all‐cause mortality compared with shorter intervals (2‐5 days) (control) between dressing changes (low certainty).
1 finding from 1 review
RR 1.06 [0.9, 1.25]
Studies not reported
Low
Skin damage № of participants: 1587 (4 RCTs) · patients with a central venous catheter
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Pain № of participants: 193 (2 RCTs) · patients with a central venous catheter
Longer intervals (5‐15 days) (intervention) showed no clear difference in pain № of participants: 193 (2 RCTs) compared with shorter intervals (2‐5 days) (control) between dressing changes (low certainty).
1 finding from 1 review
RR 0.8 [0.46, 1.38]
Studies not reported
Low
Gait assessment · rehabilitation in Parkinson's disease
3 findings from 1 review
no estimate extracted
4 studies · 129 participants
Low
no estimate extracted
3 studies · 106 participants
Low
no estimate extracted
3 studies · 106 participants
Low
Quality of life ( · rehabilitation in Parkinson's disease
1 finding from 1 review
Adverse events · rehabilitation in Parkinson's disease
1 finding from 1 review
Balance ( · rehabilitation in Parkinson's disease
2 findings from 1 review
Quality of life ( · rehabilitation in Parkinson's disease
1 finding from 1 review
Number of adverse events · rehabilitation in Parkinson's disease
1 finding from 1 review
Gait (stride length and velocity) · rehabilitation in Parkinson's disease
1 finding from 1 review
Balance ( · rehabilitation in Parkinson's disease
1 finding from 1 review
Re‐admission during · Adults with acute asthma
Adults: higher dose/longer course showed no clear difference in re‐admission in compared with lower dose/shorter course (low certainty).
1 finding from 1 review
Re‐admission during · children with acute asthma
1 finding from 1 review
Asthma symptoms · children with acute asthma
Children: higher dose/longer course showed no clear difference in asthma symptoms Symptom free by 7 days compared with lower dose/shorter course (moderate certainty).
1 finding from 1 review
Serious adverse events · children with acute asthma
1 finding from 1 review
Exacerbations · children with acute asthma
Children: higher dose/longer course showed no clear difference in new exacerbation during compared with lower dose/shorter course (low certainty).
2 findings from 1 review
FEV1 % predicted · children with acute asthma
1 finding from 1 review
All adverse events · children with acute asthma
Children: higher dose/longer course showed no clear difference in all adverse events compared with lower dose/shorter course (moderate certainty).
1 finding from 1 review
Asthma severity and symptoms · Adults with acute asthma
1 finding from 1 review